Progress in immune hemolytic anemia caused by drugs
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 6
Abstract
Drug-induced immune hemolytic anemia (DIIHA) is a rare cytopenia caused by damage to RBCs by drug-induced antibodies or non-immune protein adsorption (NIPA). The drugs associated with DIIHA and the mechanistic hypotheses that are thought to be involved have been controversial, with complex serological tests often required by specialized Immune Hematology laboratories for diagnosis. It is necessary to know the clinical manifestation and laboratory diagnosis of DIIHA in order to distinguish the immuno-hematological abnormality caused by drugs from other causes. How to improve the diagnostic ability of DIIHA and establish a scientific and reasonable idea of DIIHA serological examination is urgent to help clinical diagnosis and correct treatment.
Authors and Affiliations
Xinyan LONG, Leiping WANG, Yinze ZHANG, Qingbao MENG
Keywords
Related Articles
- EP ID EP738578
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.06.022
- Views 55
- Downloads 0
Molecular genetic analysis and identification of novel alleles of ABO subtypes
Objective To study the molecular mechanism of 95 samples of serological ABO subtypes. Methods A total of 95 samples with discrepancy between forward and reverse blood grouping were subjected to serological confirmation,...
Characteristics of elderly apheresis platelet donors and analysis of pre-donation testing results
Objective To study and analyze the characteristics of 56-60 years old apheresis platelet donors and the results of pre-donation blood testing in Tianjin, so as to provide reference for the management of blood stations an...
Overview of national plan for NHS blood and transplant and hospitals to address blood shortage in the United Kingdom (Series 1): Emergency management framework
As a vital resource, blood directly impacts the life and health of patients and the continuity of medical care. Given that it can only be obtained through voluntary donations from blood donors, its supply is susceptible...
Progress in clinical application of autologous ozonized blood transfusion
Autologous ozonized blood transfusion (AOBT) is a therapeutic method that mixes blood with medical ozone in vitro and then reinfuses it into the body. It has been widely used in the auxiliary treatment of ischemia, hypox...
Explore of nanopore sequencing technology in ambiguities of HLA genotyping
[Objective] To resolve the ambiguities of HLA genotyping generated by next generation sequencing (NGS) using nanopore sequencing technology. [Methods] A total of 38 samples with ambiguous HLA genotyping by NGS in our lab...